Sanofi SA
DUS:SNW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sanofi SA
DUS:SNW
|
FR |
|
M
|
Microsoft Corp
F:MSF
|
US |
Intrinsic Value
The intrinsic value of 
Sanofi SA (SNW) under the Base Case is 105.93 EUR per share.
Compared with the current market price of 80.12 EUR, the stock appears
Undervalued by 24% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Sanofi Does
Sanofi is a global healthcare company that discovers, develops, makes, and sells prescription medicines and vaccines. Its main products cover areas like immunology, rare diseases, neurology, diabetes, and infectious diseases, along with preventive vaccines used by doctors, hospitals, public health systems, and pharmacies.
- Headquarters
- France FR
- Employees
- 74 846
- IPO date
- Jul 1, 2002
Sanofi has no economic moat
Patent protection keeps copies of some Sanofi medicines out, but it does not prevent rivals from developing alternative treatments. Competition against older medicines shows that these product-level protections do not provide a lasting shield across the company.
Read the full moat analysis
Earnings Waterfall
Sanofi SA
The intrinsic value for Sanofi SA (SNW) under the Base Case is 105.93 EUR.
Compared with the current market price of 80.12 EUR, the stock appears Undervalued by 24% .
